Is Tamoxifen safe while breastfeeding?
Here is what NIH LactMed, the U.S. National Library of Medicine's authority on medicines and breastfeeding, reports about Tamoxifen. This is a summary of that source — not our own verdict.
Effects on the breastfed infant
Relevant published information was not found as of the revision date.
Effects on milk supply
Tamoxifen was more effective than placebo in suppressing lactation and preventing engorgement and pain in two trials in postpartum mothers. Neither study stated what, if any, physical methods (e.g., breast binding) were used concurrently.[ 2 , 3 ] In one study of 80 women, tamoxifen 10 mg four times daily for 5 days during the first week postpartum was more effective than placebo in suppressing a rise in serum prolactin after use of a mechanical breast pump after 5 days of treatment, but not on day 3. All of the women in the study had breastfed a previous child.[ 2 ] The other study of 150 women used 2 regimens starting within 2 hours of delivery: tamoxifen 30 mg twice daily for 2 days, followed by 10 mg twice daily for 2 days; and 10 mg twice daily for 14 days. More women in the tamoxifen groups had not previously breastfed an infant.[ 3 ] In a case report, a woman with a history of breastfeeding 4 children (the last having been weaned 10 months earlier) began lactating after 1 week of a cancer chemotherapy regimen for breast cancer that included tamoxifen 20 mg/day. Milk production continued for several weeks until tamoxifen was discontinued after which it did not return during 12 more weeks of chemotherapy.[ 4 ]
Levels in milk
Maternal Levels. A nursing mother was diagnosed with breast cancer and started on tamoxifen 20 mg daily at 8 am. Thirty-nine milk samples were collected over 23 days before and after tamoxifen initiation. For the first 15 days, two samples were collected each day, one in the afternoon and one in the evening. For the remaining 8 days, only one sample was collected each day. On day 1 of therapy, tamoxifen was detected in a concentration of 16.5 mcg/L at noon and 13.9 mcg/L at 11 pm. Milk concentrations increased steadily to a concentration of 79.5 mcg/L at an unrecorded time on day 23. Seven metabolites were also monitored and increased over the same time period. The two active metabolites, 4-hydroxytamoxifen and Z-endoxifen also increased over time and reached quantifiable levels at day 18. The authors noted that steady-state might not have been attained at the time of the last milk sample.[ 1 ] Infant Levels. Relevant published information was not found as of the revision date.
Source: NIH LactMed (National Library of Medicine).
Educational summary of an authoritative source — not medical advice. Never start, stop, or change a medicine while breastfeeding without confirming with your doctor.